Table 9 Total annual direct medical and non-medical costs of FRDA in the United Kingdom (n=75)
From: Impact of Friedreich’s Ataxia on health-care resource utilization in the United Kingdom and Germany
Direct medical cost | Cost | Proportion of total direct medical cost |
|---|---|---|
Hospitalizations | £50,067 | 21% |
Community / Outpatient Consultations | £71,888 | 30% |
Prescription Medications | £83,456 | 34% |
Non-prescription Medications | £36,903 | 15% |
Total direct medical cost | £242,314 | |
Direct non-medical cost | Cost | Proportion of Total Direct Non - Medical Cost |
Educational Support | £14,688 | 4.5% |
Respite Care | £3,584 | 1.1% |
Professional Caregiver Support | £304,668 | 94.3% |
Total direct non-medical cost | £322,940 | |
Direct non-medical cost including long term adaptation and mobility costs | Cost | Proportion of total direct non - medical costs |
Modification / Adaptation | £44,268 | 10.43% |
Mobility | £57,419 | 13.52% |
Total direct non-medical cost with long term costs | £424,627 | |
Total direct cost excluding modification and mobility costs | £565,254 | |
Total direct cost including modification and mobility costs | £666,941 |